Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

R&D Mash-ups

Changing demands in drug development lead to new service combinations and models.
Sep 2, 2010

Changing demands in drug development lead to new service combinations and models.

Be Careful for What You Wish

Rising labor costs in China may result in increased competition for higher value services.
Aug 4, 2010

Rising labor costs in China may result in increased competition for higher value services.

Slow Climb Back

The health of the contract-services industry is improving but the market is signaling tougher competition ahead. This article is part of the 2010 Outsourcing Resources special issue.
Aug 1, 2010

The health of the contract-services industry is improving but the market is signaling tougher competition ahead. This article is part of the 2010 Outsourcing Resources special issue.

EU Debt Crisis Adds Uncertainty

The sovereign debt crisis in the EU could greatly change the landscape for contract services.
Jul 7, 2010

The sovereign debt crisis in the EU could greatly change the landscape for contract services.

Be Careful for What You Wish

Rising labor costs in China may result in increased competition for higher value services.
Jul 2, 2010

Rising labor costs in China may result in increased competition for higher value services.

Be Careful What You Wish For

Jul 1, 2010

Rising labour rates in China may reduce its cost advantage, but will probably result in western suppliers facing more competition for higher value services.

EU Debt Crisis Adds Uncertainty

The sovereign debt crisis in the EU could greatly change the landscape for contract services.
Jun 2, 2010

The sovereign debt crisis in the EU could greatly change the landscape for contract services.

EU debt crisis adds uncertainty for contract services

Having barely begun recovering from the economic slump that began in 2008, the contract services industry must now face the consequences of the debt crisis in Europe, which will include reduced bio/pharmaceutical expenditure by governments. CMOs will feel the effect of this in fewer batches and increased pressure to reduce prices.
Jun 1, 2010

Having barely begun recovering from the economic slump that began in 2008, the contract services industry must now face the consequences of the debt crisis in Europe, which will include reduced bio/pharmaceutical expenditure by governments.

The Lilly Way

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.
May 5, 2010

Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here